BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response-Reference-Cited by-同舟云学术

BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response

Published:2021-08 Issue:8 Volume:40 Page:759-762
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Peled Yael,Ram Eilon,Lavee Jacob,Sternik Leonid,Segev Amit,Wieder-Finesod Anat,Mandelboim Michal,Indenbaum Victoria,Levy Itzchak,Raanani Ehud,Lustig Yaniv,Rahav Galia

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference10 articles.

1. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

2. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey;Lancet,2021

3. Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients;Boyarsky;JAMA,2021

4. Safety of the first dose of SARS-CoV-2 vaccination in solid organ transplant recipients;Boyarsky;Transplantation,2021

5. International Society for Heart and Lung Transplantation Guidance from the International Society of Heart and Lung Transplantation regarding the SARS CoV-2 pandemic. Available at: https://ishlt.org/ishlt/media/Documents/COVID19_Vaccine-Recommendations_3-15-2021.pdf

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates—2024;The Journal of Heart and Lung Transplantation;2024-10

2. Effect of antimetabolite regimen on cellular and humoral immune response to SARS-COV-2 vaccination in solid organ transplant recipients;Immunology Letters;2024-08

3. Remdesivir and molnupiravir had comparable efficacy in lung transplant recipients with mild-to-moderate COVID-19: a single center experience;Frontiers in Transplantation;2024-07-04

4. Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience;Medicina Clínica (English Edition);2024-04

5. Evolution of the impact of the COVID‐19 pandemic on heart transplant recipients: Decreasing risk, improving perspective;Transplant Infectious Disease;2024-02-20